rAAV-PD-L1-scFv

N/A

Report date: 2022/11/17 17:33:28

Base Information

Drug NamerAAV-PD-L1-scFv
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionAnti-Programmed death-ligand 1
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsColorectal NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Alabama At Birmingham
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Alabama At Birmingham
Inactive CompaniesN/A
Active IndicationsColorectal NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A